Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilot
Open Access
- 23 June 2019
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 96 (2) , 137-142
Abstract
Objectives: Understanding the public health impact of lymphogranuloma venereum (LGV) in Europe is hampered by inadequate diagnostics and surveillance systems in many European countries. We developed and piloted LGV surveillance in three European countries without existing systems and performed a preliminary investigation of LGV epidemiology, where little evidence currently exists.Methods: We recruited STI or dermatovenereology clinics and associated laboratories serving men who have sex with men (MSM) in Austria, Croatia and Slovenia, using the UK for comparison. We undertook centralised LGV testing ofChlamydia trachomatis(CT)-positive rectal swabs collected between October 2016 and May 2017 from MSM attending these clinics. Stored specimens from Austria (2015–2016) and Croatia (2014) were also tested. Clinical and sociodemographic data were collected using a standardised proforma. TheompAgene of LGV-positive specimens was sequenced.Results: In total, 500 specimens from CT-positive MSM were tested, and LGV positivity was 25.6% (128/500; 95% CI 22.0% to 29.6%) overall, and 47.6% (79/166; 40.1% to 55.2%) in Austria, 20.0% (3/15; 7.1% to 45.2%) in Croatia, 16.7% (1/6; 3.0% to 56.4%) in Slovenia and 14.4% (45/313; 10.9% to 18.7 %) in the UK. Proformas were completed for cases in Croatia, Slovenia and in the UK; proformas could not be completed for Austrian cases, but limited data were available from line listings. Where recorded, 83.9% (78/93) of LGV-CT cases were HIV-positive compared with 65.4% (149/228) of non-LGV-CT cases; MSM with LGV-CT were more likely to have proctitis (Austria, 91.8% vs 40.5%, pompAsequences were identified, including three new variants; the L2ompAsequence predominated (58.6%, 51/87).Conclusions: LGV is substantially underdiagnosed in MSM across Europe. Unified efforts are needed to overcome barriers to testing, establish effective surveillance, and optimise diagnosis, treatment and prevention.Keywords
Funding Information
- European Centre for Disease Prevention and Control (NP/2016/OCS/5814/01)
This publication has 24 references indexed in Scilit:
- 2013 European guideline on the management of lymphogranuloma venereumJournal of the European Academy of Dermatology and Venereology, 2014
- Clinical and epidemiological characterization of a lymphogranuloma venereum outbreak in Madrid, Spain: co-circulation of two variantsClinical Microbiology and Infection, 2014
- Characteristics of LGV repeaters: analysis of LGV surveillance data: Table 1Sexually Transmitted Infections, 2014
- Lymphogranuloma venereum diagnoses among men who have sex with men in the UK: interpreting a cross-sectional study using an epidemic phase-specific frameworkSexually Transmitted Infections, 2013
- High-risk drug practices in men who have sex with menThe Lancet, 2013
- Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, GermanyEmerging Infectious Diseases, 2013
- Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typingNature Genetics, 2012
- The Molecular Diagnosis of Lymphogranuloma Venereum: Evaluation of a Real-Time Multiplex Polymerase Chain Reaction Test Using Rectal and Urethral SpecimensSexually Transmitted Diseases, 2007
- Real-time Polymerase Chain Reaction To Diagnose Lymphogranuloma VenereumEmerging Infectious Diseases, 2005
- SARS Coronavirus Detection MethodsEmerging Infectious Diseases, 2005